Access the latest news about Vidium and veterinary cancer diagnostics while exploring upcoming conferences and event information.
October 13-15, 2022; Norfolk, VA
Join us to view posters “Mutation landscape and clinical actionability in canine melanoma” by Vidium expert Dr. Esther Chon, and “Development and Validation Procedures for Improving SearchLight DNA, a Canine Cancer Genomic Diagnostic Panel” by Vidium’s bioinformatician Manisha Warrier.
October 14, 2022, 8am EST; Norfolk, VA
Join Dr. Esther Chon in panel discussion “Options & Evidence: Novel Diagnostics Panel Discussion”
June 23-25, 2022; Austin, TX
Join us to hear talks presented by Vidium experts Dr. Guannan Wang, Dr. Esther Chon and Dr. Derick Whitley
January 15–19, 2022; Orlando, FL
Come visit us at Booth # 930
If you would like to meet with our team while at the conference or discuss a case: SCHEDULE A MEETING
March 6-9, 2022; Las Vegas, NV
If you would like to meet with our team while at the conference or discuss a case: SCHEDULE A MEETING
April 9-12, 2022; Puerto Vallarta, Mexico
If you would like to meet with our team while at the conference or discuss a case: SCHEDULE A MEETING
An evaluation study published in the March 2023 issue of the Journal of the American Veterinary Medical Association supports the use of tumor genomic testing for dogs with cancer, particularly those with ambiguous cancer diagnoses.
Vidium Animal Health announced® today that it has partnered with Torigen Pharmaceuticals, an animal health biologics company, to offer genomic testing and precision medicine to more veterinarians.
Vidium Animal Health® announced today that it has entered a reseller agreement with Antech Diagnostics® to…
Torigen Pharmaceuticals, Inc, a commercial-stage animal health biologics company, today announced it has…
Vidium Animal Health® announced that it has added specialty pathology services to its in-house genomic and molecular diagnostic testing capabilities and has…
Vidium Animal Health announced that it is presenting virtually at the Biotech Showcase™ 2022 conference, January 10-19…
Vidium Animal Health announced it has more than doubled the size of its management team since the company launched in …
After more than a decade of pioneering the study of naturally occurring cancer in pet dogs, the Translational Genomics …
Ethos Veterinary Health, Ethos Discovery, and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, announced today …
